首页 | 本学科首页   官方微博 | 高级检索  
     


Phase II,open‐label trial of lapatinib and vinorelbine in women with previously treated HER2‐positive metastatic breast cancer
Authors:Arlene Chan  Catherine Shannon  Richard de Boer  Sally Baron‐Hay  Andrew Redfern  Astrid Bauwens  Paul Craft  Suzanne Webb  Amanda Townsend  Dusan Kotasek
Affiliation:1. Department of Medical Oncology, Breast Cancer Research Centre‐WA and Curtin University, , Perth, Western Australia, Australia;2. Adult Mater Hospital, , Brisbane, Queensland, Australia;3. Epworth–Freemasons Hospital, , Melbourne, Victoria, Australia;4. Royal Northshore Hospital, , Sydney, New South Wales, Australia;5. Royal Perth Hospital, , Perth, Western Australia, Australia;6. Canberra Hospital, , Canberra, Australian Capital Territory, Australia;7. St John of God, , Subiaco, Western Australia, Australia;8. Medical Oncology, Queen Elizabeth Hospital, , Adelaide, South Australia, Australia;9. Adelaide Cancer Centre, , Kurralta, South Australia, Australia
Abstract:
Keywords:HER2‐positive breast cancer  lapatinib/capecitabine  post‐trastuzumab
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号